Jiangsu Yabang Aipusheng Pharmaceutical

Jiangsu Yabang Aipusheng Pharmaceutical is a prominent Chinese pharmaceutical manufacturer focused on the production of active pharmaceutical ingredients (APIs) and finished dosage forms. Based in Changzhou, the company operates as a key subsidiary of the Yabang Investment Holding Group and maintains extensive GMP-compliant manufacturing facilities. Its therapeutic focus includes cardiovascular medicine, anti-infectives, and gastroenterology, with a portfolio featuring widely used generics such as amlodipine and azithromycin. The company plays a significant role in the global pharmaceutical supply chain, providing both proprietary products and contract manufacturing services. Jiangsu Yabang Aipusheng Pharmaceutical is recognized for its large-scale industrial capacity and commitment to international quality standards.